why choose us

300×250 Ad Slot

Research Article: Immune-related adverse events of anti-PD-1 immune checkpoint inhibitors: a single center experience

Date Published: 2023-10-17

Introduction:
Objectives: Immune checkpoint inhibitors (ICIs) stimulate antitumor immune responses and, in parallel, they might trigger autoimmune and other immunopathological mechanisms eventually leading to immune-related adverse events (irAE). In our study, we assessed patients with malignancies who underwent anti-PD-1 treatment at the University of Debrecen, Clinical Center.

Read more

300×250 Ad Slot